The American Society of Human Genetics (ASHG) is deeply troubled by the recent layoffs at the National Institutes of Health (NIH), the Advanced Research Projects Agency for Health (ARPA-H), National Science Foundation (NSF) and other agencies. These abrupt and unilateral decisions have far-reaching consequences that extend beyond the immediate loss of jobs. The impact on... Read More
The American Society of Human Genetics released the following statement in response to the recent announcement from the National Institutes of Health (NIH) regarding the implementation of a 15% reimbursement rate cap for Facilities and Administration (F&A) costs, applicable to both new and existing grants as of February 10. Although a temporary restraining order is... Read More
Just a few days after winning the election, the incoming Trump Administration began to identify key health policy proposals. Some of these priorities include addressing mental health issues and tackling the opioid overdose crisis, accelerating translational research, and improving rural health. The National Institutes of Health (NIH) remains under scrutiny, with ongoing discussions surrounding its... Read More
For Immediate Release: August 5, 2024, 11:30 a.m. U.S. Eastern Time Media Contact: Kara Flynn, (202) 257-8424, press@ashg.org American Society of Human Genetics (ASHG) President Bruce D. Gelb, M.D., released the following statement in response to the U.S. Senate Appropriations Committee’s approval by a 25-3 vote of the fiscal year (FY) 2025 bill for the... Read More
In May 2024, ASHG hosted a fourth year of virtual advocacy meetings with policymakers on Capitol Hill. Over the course of a week, participants in the 2024 cohort of the Advocacy Certificate for Human Genetics and Genomics Trainees (ACGT) program joined members of past ACGT cohorts and members of the Government and Public Advocacy Committee (GPAC) in meetings with 15 congressional... Read More
ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy